Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2024

Jan 30, 2024

3535_rns_2024-01-30_af49af38-668c-41aa-9511-b60f6a9c0413.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

AQUA BIO TECHNOLOGY ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

30.1.2024 10:34:32 CET | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 30 January

2024 concerning, among other things, a private placement with total gross

proceeds of approximately NOK 12.46 million and a contemplated subsequent

offering (the "Subsequent Offering").

Date on which the terms of the Subsequent Offering was | 29 January 2024

announced: |

------------------------------------------------------------------------

Last day including right: | 30 January 2024

------------------------------------------------------------------------

First day excluding right: | 31 January 2024

------------------------------------------------------------------------

Record date: | 1 February 2024

------------------------------------------------------------------------

Resolution date: | 30 January 2024

------------------------------------------------------------------------

Maximum number of new shares: | 1,000,000

------------------------------------------------------------------------

Subscription price: | NOK 5

------------------------------------------------------------------------

Shall the rights be listed | No

The formal resolution related to the Subsequent Offering will be made by the

board of directors at a later time, and further information will be given in due

course.

This information is published in accordance with the requirements of the

Continuing Obligations.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2876/4006/Download%20announcement

%20as%20PDF.pdf